GORE TAG Conformable Thoracic Endoprosthesis TGU373710Recalls & reported problems
W. L. Gore & Associates, Inc. · TAG THORACIC ENDO CONFORM 37mmX10cm 24Fr · Class 3 · Implant
All models of GORE TAG Conformable Thoracic Endoprosthesis (20)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 7
- Deaths reported
- 1
- Injuries reported
- 5
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 7 adverse event reports that list this exact device (DI 00733132617722), received between May 10, 2018 and Aug 26, 2020 — classified as 1 death, 5 injuries, 1 malfunction.
The most frequently reported specific device problem is “Break” (1 report).
6 other recalls cover devices cleared under the same FDA submission (P040043); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem4
- Break1
- Detachment Of Device Component1
- Improper or Incorrect Procedure or Method1
- No Apparent Adverse Event1
- Patient-Device Incompatibility1
Patient problems
- Aneurysm2
- No Known Impact Or Consequence To Patient2
- Death1
- Foreign Body In Patient1
- No Consequences Or Impact To Patient1
- Not Applicable1
Recent adverse event reports
The 7 most recent of 7 reports, in the reporter's own words as published by the FDA.
InjuryAug 26, 2020Improper or Incorrect Procedure or Method; Improper or Incorrect Procedure or Method
ON (B)(6) 2020 THE PATIENT UNDERWENT OPEN TREATMENT OF A RUPTURED ABDOMINAL AORTIC ANEURYSM USING CONFORMABLE GORE® TAG® THORACIC ENDOPROSTHESES. ON JULY 27, 2020 THE PHYSICIAN MADE THE FIELD SALES ASSOCIATE AWARE OF AN ENDOLEAK OBSERVED ON IMAGING. THE ENDOLEAK WAS SUSPECTED TO BE EITHER A TYPE III ENDOLEAK OR A GUTTER LEAK. ON (B)(6) 2020 A REINTERVENTION WAS PERFORMED TO TREAT THE ENDOLEAK. REPORTEDLY IT WAS SUSPECTED THAT THE PATIENT HAD A GUTTER LEAK ORIGINATING FROM THE AREA WHERE THE LEFT RENAL ARTERY STENT WAS PLACED PARALLEL (USING A PERISCOPE TECHNIQUE) ALONGSIDE THE 37MMX10CM CONFORMABLE GORE® TAG® THORACIC ENDOPROSTHESIS. A RETROGRADE LEAK OFF OF THE LEFT RENAL ARTERY STENT WAS ALSO NOTED. THE PHYSICIAN PLACED A 37MMX10CM GORE® TAG® CONFORMABLE THORACIC STENT GRAFT WITH ACTIVE CONTROL SYSTEM AND A BARD 6MMX58MM LIFESTREAM STENT TO TREAT THE ENDOLEAK. THE GUTTER LEAK WAS COIL EMBOLIZED USING VARIOUS COILS. AN ADDITIONAL 8MM STENT WAS PLACED IN THE PATIENT'S LEFT RENAL ARTERY. THE ENDOLEAK APPEARED TO BE RESOLVED. THERE WERE NO FURTHER REPORTED ISSUES. THE PATIENT TOLERATED THE REINTERVENTION.
Patient problems: No Known Impact Or Consequence To Patient
MAUDE report 10452391 ↗InjuryMar 17, 2020Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
THERE WAS ANEURYSM SAC ENLARGEMENT (AMOUNT OF ENLARGEMENT IS UNKNOWN). THE CAUSE OF THE ENDOLEAK IS UNKNOWN. ON (B)(6) 2020, THE DEVICES WERE EXPLANTED AND OPEN SURGICAL CONVERSION WAS PERFORMED. THE PATIENT TOLERATED THE REINTERVENTION.
Patient problems: Aneurysm
MAUDE report 9843704 ↗InjuryNov 2, 2019Adverse Event Without Identified Device or Use Problem; No Apparent Adverse Event; Adverse Event Without Identified Device or Use Problem; No Apparent Adverse Event
THE FOLLOWING INFORMATION WAS REPORTED TO GORE: ON (B)(6) 2019 A PATIENT WAS UNDERGOING TREATMENT OF AN ANEURYSMAL TYPE B THORACIC AORTIC DISSECTION, ZONE 2 WITH GORE® TAG® THORACIC BRANCH ENDOPROSTHESES AND A CONFORMABLE GORE® TAG® THORACIC ENDOPROSTHESIS AS DISTAL EXTENSION TO AORTIC COMPONENT. THE PRE-TREATMENT MAXIMUM AORTIC DIAMETER WITHIN THE TREATED SEGMENT HAS NOT BEEN RECORDED IN THE CLINICAL STUDY DATABASE. ACCORDING TO THE REPORT ALL DEVICES WERE POSITIONED AND IMPLANTED WITHOUT ISSUE. ON (B)(6) 2019 AN ASYMPTOMATIC, UNSPECIFIED ENDOLEAK WAS REPORTED. THERE WAS NO ANEURYSM ENLARGEMENT REPORTEDLY ASSOCIATED WITH THE ENDOLEAK. ON (B)(6) 2019 AN EMBOLIZATION PROCEDURE WAS PERFORMED TO ADDRESS THE ENDOLEAK. FOLLOWING THE PROCEDURE THE ENDOLEAK WAS RESOLVED.
Patient problems: No Known Impact Or Consequence To Patient; Not Applicable
MAUDE report 9270517 ↗DeathJun 13, 2019Patient-Device Incompatibility; Patient-Device Incompatibility
ON (B)(6) 2014, THIS PATIENT UNDERWENT ENDOVASCULAR REPAIR OF A THORACOABDOMINAL AORTIC ANEURYSM USING GORE® TAG® THORACIC ENDOPROSTHESES. ON (B)(6) 2016, A PROCEDURE OCCURRED WHEREBY A GORE® VIABAHN® ENDOPROSTHESIS WAS IMPLANTED IN THE SUPERIOR MESENTERIC ARTERY TO EXTEND A PREVIOUSLY IMPLANTED GRAFT (UNKNOWN MANUFACTURER). ON (B)(6) 2019, COMPUTED TOMOGRAPHY IMAGING SHOWED AN UNSTABLE TYPE II ENDOLEAK AT THE LEVEL OF THE MID/DISTAL THORACIC AORTA, WITH EVIDENCE OF RUPTURE OF THE ANEURYSM AND BLEEDING INTO THE LEFT PLEURAL SPACE. AFTER DISCUSSION WITH THE PATIENT ABOUT ENDOVASCULAR REPAIR VS OPEN REPAIR VS COMFORT MEASURES, THE PATIENT ELECTED FOR PALLIATIVE CARE CONSULT AND TO PURSUE COMFORT MEASURES. THE PATIENT EXPIRED ON (B)(6) 2019.
Patient problems: Death
MAUDE report 8695861 ↗InjuryDec 21, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2016, THE PATIENT UNDERWENT ENDOVASCULAR REPAIR OF A THORACIC AORTIC ANEURYSM USING A CONFORMABLE GORE® TAG® THORACIC ENDOPROSTHESES. IT WAS REPORTED THAT ON (B)(6) 2018, THE PATIENT PRESENTED WITH HEMOLYSIS. A TYPE III ENDOLEAK WITH COMPONENT SEPARATION WAS IDENTIFIED. THERE WAS EXCESSIVE OVERLAP BETWEEN THE ORIGINAL IMPLANTED CONFORMABLE GORE® TAG® THORACIC ENDOPROSTHESES (TGU373710/12562071 AND TGU373710/14491031) AND THEREFORE THE TGU454510/14820255 DISCONNECTED FROM BOTH IMPLANTED DEVICES. THE PHYSICIAN REINTERVENED AND BRIDGED THE COMPONENT DISCONNECTION BY IMPLANTING A CONFORMABLE GORE® TAG® THORACIC ENDOPROSTHESIS (TGU454520/18712623). THE PATIENT TOLERATED THE PROCEDURE.
Patient problems: Aneurysm
MAUDE report 8192249 ↗InjurySep 13, 2018Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
ON (B)(6) 2018, A PATIENT UNDERWENT ENDOVASCULAR TREATMENT IN THE THORACIC AORTA, ZONE 2, WITH GORE® TAG® THORACIC BRANCH ENDOPROSTHESES AND CONFORMABLE GORE® TAG® THORACIC ENDOPROSTHESES. THE PATIENT TOLERATED THE INITIAL PROCEDURE. IT WAS REPORTED THAT DURING THE INITIAL PROCEDURE A TYPE II ENDOLEAK WAS DETERMINED. ON (B)(6) 2018, THE PATIENT UNDERWENT THE ADDITIONAL PROCEDURE WITH A STENT PLACEMENT. THE EVENT IS ONGOING. THE PATIENT WAS DISCHARGED FROM THE HOSPITAL ON (B)(6) 2018.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 7875403 ↗MalfunctionMay 10, 2018Break; Detachment Of Device Component
THE "NOSE CONE" (TIP) BROKE OFF THE INSTRUMENT INSIDE OF THE PATIENT.
Patient problems: Foreign Body In Patient
MAUDE report 7506279 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under P040043. One submission often covers many models, so check the product and lot details in each record.
- Z-0290-2021 · Sep 9, 2020 · Open, ClassifiedGORE TAG CONFORMABLE Thoracic Stent Graft with ACTIVE CONTROL System
- Z-0291-2021 · Sep 9, 2020 · Open, ClassifiedGORE TAG Conformable Thoracic Stent Graft with ACTIVE CONTROL System
- Z-2052-2020 · Dec 17, 2019 · TerminatedConformable Thoracic Stent Graft, Rx only, Sterile EO - Product Usage: This device is intended for endovascular repair of lesions of the descending thoracic aorta.
- Z-0048-2018 · Sep 25, 2017 · TerminatedGORE TAG, THORACIC ENDOPROSTHESIS, CONFORMABLE. The GORE TAG Thoracic Endoprosthesis is intended for endovascular repair of all lesions of the descending thoracic aorta.
- Z-1236-06 · Apr 28, 2006 · TerminatedGORE TAG THORACIC ENDOPROSTHESIS System, Endovascular Graft, Aortic Aneurysm Treatment, Catalogue Number TG3410, 34mm x 10cm
- Z-1237-06 · Apr 28, 2006 · TerminatedGORE TAG THORACIC ENDOPROSTHESIS System, Endovascular Graft, Aortic Aneurysm Treatment, Catalogue Number TG3415, 34mm x 15cm
Other System, Endovascular Graft, Aortic Aneurysm Treatment devices
- Endurant® IIs ESBF2814C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls34 deaths254 reports
- Endurant® IIs ESBF3214C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls19 deaths173 reports
- Endurant® IIs ESBF3614C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT1 recall37 deaths214 reports
- Endurant® IIs ESBF2514C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls18 deaths136 reports
- Endurant® IIs ESBF2314C103EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls9 deaths60 reports
- RelayPro Thoracic Stent-Graft System 28-N4-34-154-34UBolton Medical Inc. · System, Endovascular Graft, Aortic Aneurysm Treatment3 recalls7 reports
- Vela Proximal Endograft System A34-34/C100-O20 VEndologix LLC · System, Endovascular Graft, Aortic Aneurysm Treatment3 deaths152 reports
- Endurant® II ETCF2828C49EMedtronic, Inc. · SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT2 recalls7 deaths44 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page